Categories: Invest

Should I sell Altria Group shares after RBC lowered its rating?

Altria Group, Inc. (NYSE: MO) shares have advanced more than 10% since the beginning of January 2022, and the current share price stands at $54.

RBC Capital Markets lowered its rating on Altria Group

Altria Group is an American corporation and one of the world’s largest producers and marketers of tobacco, cigarettes, and related products. Altria Group has a strong demand for its products, and the company reported better than expected fourth-quarter results in January.


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

Total revenue has increased by 0.8% Y/Y to $5.09 billion, which was above the expectations, while the non-GAAP EPS for the fourth fiscal quarter was $1.09 (beats by $0.01). Billy Gifford, Chairman & CEO, said:

Our plans for the 2022 year include a continuation of our strategy to balance earnings growth and shareholder returns with investments toward our Vision. We expect to deliver 2022 full-year adjusted diluted EPS in a range of $4.79 to $4.93, representing a growth rate of 4% to 7% from an adjusted diluted EPS base of $4.61 in 2021.

Altria Group declared a $0.90/quarterly share dividend in February, payable on April 29 to stockholders of record as of March 25, 2022. The current dividend yield remains above 6%, which makes this stock attractive for dividend-oriented investors.

Despite this, RBC Capital Markets lowered its rating on Altria Group recently and reported that Altria shares have limited room for further upside.

According to RBC Capital Markets, oil prices will remain high for the upcoming quarters, which means the trade down in the cigarette category may continue.

RBC Capital Markets announced that recent scanner data trends are noted to have shown Marlboro is still losing market share, and RBC assigned a $53 price target on Altria shares.

Fundamentally looking, Altria Group is a stable company, and with a market capitalization of $98 billion, shares of Altria remain attractive for long-term-oriented investors.

Altria Group trades at less than eight times TTM EBITDA, and the company’s management is optimistic about the upcoming years in terms of growth which is certainly positive for shareholders.

The positive trend remains intact

Data source: tradingview.com

Altria Group shares have advanced more than 10% since the beginning of the 2022 year, and according to technical analysis, the positive trend remains intact. If the price jumps above $55, the next price target could be at $57 or even $60.

The current support level stands at $50, and if the price falls below this level, it would be a “sell” signal, and we have the open way to the $45.

Summary

Altria Group shares have advanced more than 10% since the beginning of the 2022 year, and according to technical analysis, the positive trend remains intact. Altria Group has a strong demand for its products; still, RBC Capital Markets recently lowered its rating on Altria Group and reported that Altria shares have limited room for further upside.

Where to buy right now

To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:

  1. Etoro, trusted by over 13m users worldwide. Register here >
  2. bitFlyer, simple, easy to use and regulated. Register here >

*Cryptoasset investing is unregulated in some EU countries and the UK. No consumer protection. Your capital is at risk.

admin

Share
Published by
admin

Recent Posts

Is there a way for the crypto sector to avoid Bitcoin’s halving-related bear markets?

There is good reason to be afraid. Previous down markets have seen declines in excess…

2 years ago

UPS and FedEx are good dividend stocks, but which should you take?

United Parcel Service, Inc. (NYSE:UPS) and FedEx Corporation (NYSE:FDX) are two robust logistics companies. Both…

2 years ago

Bitfarms sold 3K Bitcoin as part of strategy to improve liquidity and pay debts

Canadian crypto mining firm Bitfarms sold roughly $62 million worth of Bitcoin (BTC) in June,…

2 years ago

This biotech stock is up 100% on Tuesday: here’s the catalyst

Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling…

2 years ago

Japanese film studio announces the production of a series based on crypto

Noma, a Japanese film studio, has announced that it is producing three feature films that…

2 years ago

Bitcoin price taps 5-day highs as Shiba Inu leads altcoin gains

Bitcoin (BTC) saw continued strength on June 21 as Wall Street trading opened with a…

2 years ago